Spark Therapeutics Inc (ONCE) Return on Investment ROI from the third quarter of 2019 to third quarter of 2018 and for the year 2019, average high and low, overall ranking from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Spark Therapeutics Inc   (NASDAQ: ONCE)


Spark Therapeutics Inc's ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Spark Therapeutics Inc's ROI in the third quarter of 2019?
Spark Therapeutics Inc recorded a cumulative net loss of $-65 million during 12 months ending in the third quarter of 2019, resulting in a negative return on investment (ROI) of -10.35%.

Within the Healthcare sector 236 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2019 from 0 to 3362.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Investment Change TTM -5.83 % 6.17 % 36.08 % 60.34 % 82.29 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 603 660 669 592 748
Return On Investment (TTM) -10.35 % -16.88 % -4.73 % -4.79 % -4.33 %
ONCE's Overall Ranking # 3362 # 0 # 0 # 218 # 177
Seq. Investment Change TTM -5.43 % -2.78 % 1.33 % 1.08 % 6.62 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -65 -113 -32 -32 -29

ONCE Company Profile >> Back to ONCE Roi Comparisons >> See Annual ONCE Return On Investment



Return On Investment ONCE's Ranking
Within: No.
Industry # 18
Sector # 237
Overall # 3362

Return On Investment Statistics
High Average Low
33.64 %
-14.26 %
-62.16 %
(Sep 30 2018)   (Sep 30 2017)







Financial Statements
Spark Therapeutics Inc's III. Quarter Investments $ 603 Millions ONCE's Balance sheet
Spark Therapeutics Inc's III. Quarter Income $ 0 Millions Quarterly ONCE's Income Statement
ONCE's Income by Division See ONCE's Income by Division


ONCE Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 592 563 344 308 0
Y / Y Investment Growth 5.13 % 63.76 % 11.77 % - -
Net Income in Millions 0 1 -124 -47 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -0.02 % 0.17 % -35.96 % -15.32 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ONCE's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ONCE's Competitors
Subscribers only: Roi for Spark Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ONCE's Customers

Other Ratios
ONCE's Roa ONCE's Inventory Turnover Ratio ONCE's Growth Rates ONCE's Dividend Statistics
ONCE's Profitability Ratios ONCE's Asset Turnover Ratio ONCE's Dividend Growth
ONCE's Roe ONCE's Valuation Ratios ONCE's Financial Strength Ratios ONCE's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2019, within Healthcare Sector ROI

Date modified: 2026-09-08T15:09:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.